 |
|||||
|
|||||
|
|||||
|
|||||
|
|||||
The Journal of Neuroscience, June 15, 2003, 23(12):5295-5301
Previous Article | Next Article
Increased Depression-Like Behaviors in Corticotropin-Releasing Factor Receptor-2-Deficient Mice: Sexually Dichotomous Responses
Tracy L. Bale andWylie W. Vale Clayton Foundation Laboratories for Peptide Biology, The Salk Institute, La Jolla, California 92037
Depressive disorders affect nearly 19 million American adults, making depression and the susceptibility for developing depression a critical focus of mental health research today. Females are twice as likely to develop depression as males. Stress is a known risk factor for developing depression, and recent hypotheses suggest an involvement of an overactive stress axis. As mediators of the stress response, corticotropin-releasing factor (CRF) and its receptors (CRFR1 and CRFR2) have been implicated in the propensity for developing stress-related mood disorders. Mice deficient in CRFR2 display increased anxiety-like behaviors and a hypersensitive stress response. As a possible animal model of depression, these mice were tested for depression-like behaviors in the forced swim test. Comparisons were made between wild-type and mutant animals, as well as between sexes. Male and female CRFR2-mutant mice showed increased immobility as an indicator of depression compared with wild-type mice of the same sex. In addition, mutant and wild-type female mice demonstrated increased immobile time compared with males of the same genotype. Treatment of CRFR2-deficient mice with the CRFR1 antagonist antalarmin decreased immobile time and increased swim time in both sexes. We found a significant effect of sex for both time spent immobile and swimming after antalarmin treatment. Because differences in behaviors in the forced swim test are good indicators of serotonergic and catecholaminergic involvement, our results may reveal an interaction of CRF pathways with other known antidepressant systems and may also support an involvement of CRF receptors in the development of depression such that elevated CRFR1 activity, in the absence of CRFR2, increases depression-like behaviors.
Key words: CRF; CRF receptors; depression; antalarmin; forced swim test; mice
Received Nov. 18, 2002; revised Feb. 28, 2003; accepted Mar. 21, 2003.
This article has been cited by other articles:
J. I. Koenig
Corticotropin-Releasing Factor, Serotonin, and Sex: Keys to the Castle of Depressive Illness
Endocrinology, August 1, 2009; 150(8): 3440 - 3442.
[Full Text] [PDF]
J. G. McEuen, K. A. Semsar, M. A. Lim, and T. L. Bale
Influence of Sex and Corticotropin-Releasing Factor Pathways as Determinants in Serotonin Sensitivity
Endocrinology, August 1, 2009; 150(8): 3709 - 3716.
[Abstract] [Full Text] [PDF]
N. Goel and T. L. Bale
Organizational and Activational Effects of Testosterone on Masculinization of Female Physiological and Behavioral Stress Responses
Endocrinology, December 1, 2008; 149(12): 6399 - 6405.
[Abstract] [Full Text] [PDF]
J. G. McEuen, S. G. Beck, and T. L. Bale
Failure to Mount Adaptive Responses to Stress Results in Dysregulation and Cell Death in the Midbrain Raphe
J. Neurosci., August 13, 2008; 28(33): 8169 - 8177.
[Abstract] [Full Text] [PDF]
G. Kronenberg, C. Harms, R. W. Sobol, F. Cardozo-Pelaez, H. Linhart, B. Winter, M. Balkaya, K. Gertz, S. B. Gay, D. Cox, et al.
Folate Deficiency Induces Neurodegeneration and Brain Dysfunction in Mice Lacking Uracil DNA Glycosylase
J. Neurosci., July 9, 2008; 28(28): 7219 - 7230.
[Abstract] [Full Text] [PDF]
H. J. Kang, D. H. Adams, A. Simen, B. B. Simen, G. Rajkowska, C. A. Stockmeier, J. C. Overholser, H. Y. Meltzer, G. J. Jurjus, L. C. Konick, et al.
Gene Expression Profiling in Postmortem Prefrontal Cortex of Major Depressive Disorder
J. Neurosci., November 28, 2007; 27(48): 13329 - 13340.
[Abstract] [Full Text] [PDF]
R. A. Rissman, K.-F. Lee, W. Vale, and P. E. Sawchenko
Corticotropin-Releasing Factor Receptors Differentially Regulate Stress-Induced Tau Phosphorylation
J. Neurosci., June 13, 2007; 27(24): 6552 - 6562.
[Abstract] [Full Text] [PDF]
P. M. Jamieson, C. Li, C. Kukura, J. Vaughan, and W. Vale
Urocortin 3 Modulates the Neuroendocrine Stress Response and Is Regulated in Rat Amygdala and Hypothalamus by Stress and Glucocorticoids
Endocrinology, October 1, 2006; 147(10): 4578 - 4588.
[Abstract] [Full Text] [PDF]
A. Chen, E. Zorrilla, S. Smith, D. Rousso, C. Levy, J. Vaughan, C. Donaldson, A. Roberts, K.-F. Lee, and W. Vale
Urocortin 2-deficient mice exhibit gender-specific alterations in circadian hypothalamus-pituitary-adrenal axis and depressive-like behavior.
J. Neurosci., May 17, 2006; 26(20): 5500 - 5510.
[Abstract] [Full Text] [PDF]
A. Contarino and F. Papaleo
The corticotropin-releasing factor receptor-1 pathway mediates the negative affective states of opiate withdrawal
PNAS, December 20, 2005; 102(51): 18649 - 18654.
[Abstract] [Full Text] [PDF]
K. H. Skelton, C. B. Nemeroff, and M. J. Owens
Spontaneous Withdrawal from the Triazolobenzodiazepine Alprazolam Increases Cortical Corticotropin-Releasing Factor mRNA Expression
J. Neurosci., October 20, 2004; 24(42): 9303 - 9312.
[Abstract] [Full Text] [PDF]
H. Tezval, O. Jahn, C. Todorovic, A. Sasse, K. Eckart, and J. Spiess
Cortagine, a specific agonist of corticotropin-releasing factor receptor subtype 1, is anxiogenic and antidepressive in the mouse model
PNAS, June 22, 2004; 101(25): 9468 - 9473.
[Abstract] [Full Text] [PDF]
P. Forsythe, C. Ebeling, J. R. Gordon, A. D. Befus, and H. Vliagoftis
Opposing Effects of Short- and Long-term Stress on Airway Inflammation
Am. J. Respir. Crit. Care Med., January 15, 2004; 169(2): 220 - 226.
[Abstract] [Full Text] [PDF]
|
|
|
|
 |
|